Product Information
PROBENECID-COLCHICINE TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.8304 per EA under NDC 16571083201. Its NADAC has been published 132 times since Mar 27, 2024.
FDA first approved this application on Oct 24, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5; 500 mg/1; mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571083201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
COLCHICINE; PROBENECIDApproval Type
Generic (ANDA)
FDA Application
ANDA217030FDA Approved
10/24/2023
TE Code
AB
On Market Since
10/24/2023
Pharmacological Classes
Price Statistics
The NADAC for PROBENECID-COLCHICINE TABLET has been published 132 times since Mar 27, 2024, and over the history we have for it it has risen 2.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8304 per EA |
|---|---|
| All-time high | $1.0760 (Nov 13, 2024) |
| All-time low | $0.7653 (May 22, 2024) |
| 52-week high | $0.9046 |
| 52-week low | $0.7728 |
| Median price | $0.9228 |
| Average price | $0.9184 |
| Largest weekly change | +30.4% (Apr 17, 2024) |
| Weeks tracked | 132 |
| Tracking since | Mar 27, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Probenecid and Colchicine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Alkaloid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROBENECID-COLCHICINE TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PROBENECID-COLCHICINE TABLET, manufactured by Rising Pharma Holdings Inc., is $0.8304 per EA (NDC 16571083201), effective Sep 30, 2026.
How has the price of PROBENECID-COLCHICINE TABLET changed over time?
Over the history we have for it, the NADAC for PROBENECID-COLCHICINE TABLET has risen 2.9%. It has been tracked across 132 weekly CMS publications since Mar 27, 2024.
What are the highest and lowest recorded NADAC prices for PROBENECID-COLCHICINE TABLET?
Since Mar 27, 2024, the NADAC for PROBENECID-COLCHICINE TABLET has ranged from a low of $0.7653 (May 22, 2024) to a high of $1.0760 (Nov 13, 2024), with a median of $0.9228 per EA.
Are there cheaper alternatives to PROBENECID-COLCHICINE TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PROBENECID-COLCHICINE TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PROBENECID-COLCHICINE TABLET?
PROBENECID-COLCHICINE TABLET (NDC 16571083201) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.